Document is current
Any future updates will be listed below
-
Authors
Hov, Karen Roksund
Neerland, Bjørn Erik
Andersen, Anders Mikal
Undseth, Øystein
Wyller, Vegard Bruun
MacLullich, Alasdair M. J.
Skovlund, Eva
Qvigstad, Eirik
Wyller, Torgeir Bruun
-
Funding
Funding for this research was provided by:
South-Eastern Norway Regional Health Authority (2012042)
- License Information
-
More Information
Article History
Received: 17 July 2017
Accepted: 22 May 2018
First Online: 8 June 2018
Ethics approval and consent to participate
: The study was undertaken in accordance with the Declaration of Helsinki. The data and plasma samples were collected after informed consent from the patient and/or proxy (if patient was lacking capacity to consent due to delirium and/or dementia), as approved by the Regional Committee for Ethics in Medical and Health Research (South-East Norway). REK: 2013/525. None of our 20 patients were fully competent to consent to this study, so next of kin gave consent in all cases. Still, all patients were informed to the level of their capacity and all tests were voluntary at all times. Approved by The Norwegian Medicines Agency.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
